Advent International
Carlyle backs Quest Global, Bain, Advent exit
The Carlyle Group has agreed to acquire a significant minority stake in Singapore-based engineering services company Quest Global, facilitating exits for Bain Capital and Advent International.
Advent buys Australian fashion brand Zimmermann
Advent International has agreed to acquire a controlling interest in Australia-headquartered fashion brand Zimmerman, facilitating a partial exit for Italy-based private equity firm Style Capital.
China: Who’s investing?
Private equity investment in China remains in the doldrums yet local investors claim to see green shoots. Where, when, and how they engage with the market is likely to differ from previous cycles
Advent backs China pest control company
Advent international has invested an undisclosed sum in China’s LBS Group, a regionally active pest control and hygiene company.
Advent joins Series D for India's KreditBee
Advent International has committed USD 100m to Indian lending start-up KreditBee as an extension to a Series D round announced last month.
Advent acquires majority stake in India's Suven Pharma
Advent International has agreed to acquire a 50.1% stake in India-listed drug industry supplier Suven Pharmaceuticals for INR 63.1bn (USD 761.5m) with plans to acquire an additional 26%.
Hong Kong vs Singapore: No zero-sum game
Pandemic-related restrictions have dented confidence in Hong Kong as a private equity hub, while Singapore is on a roll. But gains for one don’t necessarily translate into losses for the other
Carlyle, Advent commit $1.1b to India's Yes Bank
The Carlyle Group and Advent International have together invested USD 1.1bn in India’s Yes Bank, acquiring equity shares and warrants that could enable them to own up to 20% of the lender.
Advent raises $25bn for global PE fund, targets China
Advent International has closed its largest ever global private equity fund at the hard cap of USD 25bn with plans to expand its investment activity in Greater China in the next few years.
Blackstone buys majority stake in Indian wealth manager
The Blackstone Group has acquired a majority stake in Indian wealth manager Ask Investment Managers, taking out positions held by Advent International and other investors.
Advent acquires China's largest medical capsule maker
Advent International has acquired a majority stake in Guangsheng Medicinal Capsule (GS Capsule), the largest medical capsule maker in China, for an undisclosed sum.
2022 preview: Macro & buyout
Will the bullish investment environment persist through 2022? Most Asia-based private equity players expect to remain busy, although they acknowledge a lack of visibility around macro and geopolitical risk
Tiger Global, Insight lead $220m round for India's Slice
Tiger Global Management and Insight Partners have led a $220 million round for Indian financial technology provider Slice at a valuation of about $1 billion.
Japan's Shiseido sells US makeup brands to Advent
Japan’s Shiseido has extended a program of non-core divestments with the sale of three of its US makeup brands to Advent International for $700 million.
Advent sells Chinese mattress maker to Hillhouse
Advent International has sold its controlling stake in AI Dream – operator of the Serta and King Koil mattress brands in China – to Hillhouse Capital.
Advent exits Crompton Greaves' India appliances business
Advent International has offloaded its final 5.4% holding in Crompton Greaves’ India-listed household appliances business, ending a gradual exit after a failed takeover.
Advent buys majority stake in India's ZCL, MSPEA exits
Advent International has agreed to acquire Indian pharmaceuticals supplier ZCL Chemicals, setting up a minority exit for Morgan Stanley Private Equity Asia (MSPEA).
The big C: China biotech start-ups get cutting edge on cancer
The evolution of cancer treatments in China is a bellwether for biotech development in the country and its capacity for genuine innovation. Most PE and VC investors aren’t shying away
Advent to acquire Indian pharma player
Advent International has agreed to buy a controlling stake in Indian pharmaceutical company RA Chem Pharma.
Advent buys Indian biopharma player
Advent International has agreed to acquire a controlling position in Bharat Serums and Vaccines, an Indian biopharmaceuticals supplier focused on the women’s health segment.
Advent to buy control of Indian snacks producer DFM
Advent International has agreed to acquire a 67.9% stake in Indian snacks manufacturer DFM Foods from investors including WestBridge Capital for INR8.52 billion ($118.7 million). It has made an open offer to buy a further 26% of the company for INR3.26...
Deal focus: Jollibee circles as Coffee Bean booms in Asia
The Philippines’ Jollibee Foods is set to buy US cafe chain The Coffee Bean & Tea Leaf to continue a massive Asian expansion effort. Exiting investor CDIB Capital attests to the opportunity set
PE investors exit The Coffee Bean & Tea Leaf to Jollibee
Advent International, CDIB Capital and Mirae Asset Private Equity are set to exit US-based cafe chain The Coffee Bean & Tea Leaf after the Philippines’ Jollibee Foods agreed to pay $350 million for the company.
Fund focus: Advent leverages global muscle in Asia
Advent International has up to $3 billion to deploy in Asia following its recent global fundraise. It has increased headcount to widen sector coverage